
|Videos|July 15, 2021
Incorporating Esketamine into Practice for Treatment-Resistant Depression
Advertisement
Episodes in this series

Requirements that healthcare clinics must satisfy to become a certified treatment center permitted to administer intranasal esketamine to patients with treatment-resistant depression.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
CAPS: A New Program to Support Early Intervention in Patients at Risk for Suicide
2
2025 Schizophrenia Insights: Ending the Year With Positive Data
3
Chatbot Privacy Is an Oxymoron: Assume Your Data Is Always At Risk
4
Case-Based Clinical Explorations in Schizophrenia
5









